The cloning of genes encoding melanoma antigens has opened new possibilitie
s for the treatment of patients with cancer; however, most tumor rejection
antigens recognized by tumor infiltrating lymphocytes are the products of g
enes that are also expressed by normal melanocytes. Hence, a large set of a
ntigenic determinants of the self have not induced self-tolerance and these
peptide determinants furnish target structures for immune responses direct
ed against tumors. The notion that the immunotherapeutic targets involved i
n cancer regression comprise normal differentiation antigens is stressed by
the association between vitiligo-like leukoderma, due to destruction of no
rmal melanocytes, and melanoma regression, due to destruction of cancer cel
ls. Nevertheless, this is the first report to demonstrate by means of a new
technique based on reverse transcription polymerase chain reaction and den
aturing gradient gel electrophoresis, the presence of clonally expanded T c
ells with identical BV regions in areas of destruction of both normal and n
eoplastic cells.